These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2789931)

  • 1. Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes.
    Tjia JF; Back DJ; Breckenridge AM
    Br J Clin Pharmacol; 1989 Sep; 28(3):362-5. PubMed ID: 2789931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
    Ma B; Prueksaritanont T; Lin JH
    Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of the interaction between cyclosporine and the calcium channel blocker nicardipine in renal transplant patients.
    Cantarovich M; Hiesse C; Lockiec F; Charpentier B; Fries D
    Clin Nephrol; 1987 Oct; 28(4):190-3. PubMed ID: 3319309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.
    Renton KW
    Biochem Pharmacol; 1985 Jul; 34(14):2549-53. PubMed ID: 4015695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pharmacology of calcium antagonists].
    Lauterburg BH
    Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
    Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
    Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium channel blocking agents on the reductive metabolism of halothane.
    Kawahara M; Akita S; Fujii K; Morio M
    J Appl Toxicol; 1991 Feb; 11(1):29-31. PubMed ID: 1902495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin metabolism in human liver microsomes and its inhibition by other drugs.
    Henricsson S; Lindholm A; Aravoglou M
    Pharmacol Toxicol; 1990 Jan; 66(1):49-52. PubMed ID: 2308907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients.
    Roy LF; East DS; Browning FM; Shaw D; Ogilvie RI; Cardella C; Leenen FH
    Clin Pharmacol Ther; 1989 Dec; 46(6):657-67. PubMed ID: 2689045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME; Renzulli LA
    Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine-A transport in isolated renal proximal tubular cells: inhibition by calcium channel blockers.
    Nagineni CN; Lee DB; Misra BC; Yanagawa N
    Biochem Biophys Res Commun; 1988 Dec; 157(3):1226-30. PubMed ID: 2462869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction between cyclosporin and diltiazem.
    Brockmöller J; Neumayer HH; Wagner K; Weber W; Heinemeyer G; Kewitz H; Roots I
    Eur J Clin Pharmacol; 1990; 38(3):237-42. PubMed ID: 2340843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
    Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H
    Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro identification of metabolites of verapamil in rat liver microsomes.
    Sun L; Zhang SQ; Zhong DF
    Acta Pharmacol Sin; 2004 Jan; 25(1):121-8. PubMed ID: 14704133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.